Ariana Levin, MD, assistant professor in the Department of Ophthalmology at NYU Grossman School of Medicine, discussed how open communication between the ophthalmologist or optometrist and their ...

Margaret Krackeler, MD, discusses real-world data supporting the switch from ibrutinib to zanubrutinib for chronic lymphocytic leukemia.

Adults with nonmelanoma skin cancer reported higher unadjusted levels of day-to-day mental distress, but adjusted analyses showed no significant association with depression and a slight decrease in ...

The retrospective analysis, published in the Journal of Clinical Medicine, supports the use of tildrakizumab, an interleukin-23 (IL-23) inhibitor that was FDA approved in 2018 for moderate-to-severe ...

The HELIOS-B trial previously showed that vutrisiran (Amvuttra; Alnylam Pharmaceuticals), a gene-silencing therapy that ...

Adults with allergic rhinitis experience diagnostic delays and limited access to allergen immunotherapy, impacting quality of life and treatment satisfaction. ICE activity in Minnesota healthcare ...

Dermatology is entering a "biological revolution," with engineered tissues and bio-machines offering new therapeutic ...